Telomeres and telomerase: Biological and clinical importance

Clinical Chemistry

Volumn 43, Issue 5, 1997, Pages 708-714

  Dahse, Regine ^a   Fiedler, Wolfgang ^a,b   Ernst, Günther ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

aging; cell regulation; chromosomes; tumorigenesis

Indexed keywords

ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; DNA; ENZYME INHIBITOR; RNA; TELOMERASE; TUMOR MARKER;

AGING; CARCINOGENESIS; CELL AGING; CELL IMMORTALIZATION; CELL PROLIFERATION; DNA REPLICATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; NONHUMAN; REVIEW; TELOMERE;

EID: 0030990276     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.5.708     Document Type: Review

References (55)

1. Blackburn EH, Greider CW, eds. Telomeres. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1995:1-396.
2. de Lange T. Human telomeres are attached to the nuclear matrix. EMBO J 1992;11:717-24.
3. Greider CW. Telomere length regulation. Annu Rev Biochem 1996; 65:337-65.
4. Katinka M, Bourgain F. Interstitial telomeres are hotspots for illegitimate recombination with DNA molecules injected into the macronucleus of Paramecium primaurelia. EMBO J 1992;11:725-32.
5. Kalluri R. Telomere (telomerase) hypothesis of aging and immortalization. Indian J Biochem Biophys 1996;33:88-92.
6. Brown W, MacKinnon P, Villasante A, Spurr N, Buckle VJ, Dobson MJ. Structure and polymorphism of human telomere-associated DNA. Cell 1990;63:119-32.
7. Lundblad V, Blackburn E. An alternative pathway for yeast telomere maintenance rescues est1-senescence. Cell 1993;73:347-60.
8. Biessmann H, Mason J. Genetics and molecular biology of telomeres [Review]. Adv Genet 1992;30:185-249.
9. Shampay J, Szostak J, Blackburn E. DNA sequences of telomeres maintained in yeast. Nature 1984;310:154-7.
10. Greider C, Blackburn E. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985; 43:405-13.
11. Greider C, Blackburn E. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 1987;51:887-98.
12. Singer M, Gottschling D. TLCI, template RNA component of Saccharomyces cerevisiae telomerase. Science 1994;266:404-9.
13. Feng J, Funk W, Wang S, Weinrich S, Avition A, Chiu C, et al. The RNA component of human telomerase. Science 1995;269:1236-41.
14. Morin GB. The structure and properties of mammalian telomerase and their potential impact on human disease. Sem Cell Dev Biol 1996;7:5-13.
15. Kim N, Piatyszek M, Prowse K, Harley C, West M, Ho P, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-4.
16. Olovnikov A. A theory of marginotomy. The incomplete copying of template margin in enzymatic synthesis of polynucleotides, and biological significance of the phenomenon. J Theor Biol 1973;41: 181-90.
17. Harley CB. Telomere loss, mitotic clock or genetic bomb? Mutat Res 1991;256:271-82.
18. Harley CB. Telomeres and aging. In: Blackburn EH, Greider CW, eds. Telomeres. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1995:247-63.
19. Allsopp R, Vaziri H, Patterson C, Goldstein S, Younglai E, Futcher A, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A 1992;89:10114-8.
20. Counter C, Avilion A, LeFeuvre C, Stewart N, Greider C, Harley C, Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-9.
21. Wright W, Shay J. Time, telomeres and tumours. Is cellular senescence more than an anticancer mechanism? Trends Cell Biol 1995;5:293-7.
22. Murnane J, Sabatier L, Marder B. Telomere dynamics in an immortal cell line. EMBO J 1994;13:4953-62.
23. Bryan T, Englezou A, Gupta J, Bacchetti S, Reddel R. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995;14:4240-8.
24. Lindsey J, McGill N, Lindsey L, Green D, Cooke H. In vivo loss of telomeric repeats with age in humans. Mutat Res 1991;256: 45-8.
25. Stables G, Morley W. Hutchinson-Gilford syndrome. J R Soc Med 1994;87:243-4.
26. Pennisi E. Premature aging gene discovered. Science 1996;272: 193-4.
27. Schulz V, Zakian V, Ogburn C, McKay J, Jarzebowicz A, Edland S, Martin G. Accelerated loss of telomeric repeats may not explain accelerated replicative decline of Werner syndrome cells. Hum Genet 1996;97:750-4.
28. Kruk P, Rampino N, Bohr V. DNA damage and repair in telomeres. Relation to aging. Proc Natl Acad Sci U S A 1995;92:258-62.
29. Cordon-Cardo C. Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia [Review]. Am J Pathol 1995;147:545-60.
30. Bacchetti S, Counter C. Telomeres and telomerase in human cancer [Review]. Int J Oncol 1995;7:423-32.
31. Hiyama E, Hiyama K, Yokoyama T, Ichikawa T, Matsuura Y. Length of telomeric repeats in neuroblastoma; correlation with prognosis and other biological characteristics. Jpn J Cancer Res 1992;83: 159-64.
32. Smith J, Yeh G. Telomere reduction in endometrial adenocarcinoma. Am J Obstet Gynecol 1992;167:1883-7.
33. Odagiri E, Kanda N, Jibiki K, Demura R, Aikawa E, Demura H. Reduction of telomeric length and c-erbB-2 gene amplification in human breast cancer, fibroadenoma and gynecomastia. Cancer 1994;73:2978-84.
34. Ohyashiki J, Ohyashiki K, Fujimura T, Kawakubo K, Shimamoto T, Iwabuchi A, Toyama K. Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res 1994;54:3557-60.
35. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar A, et al. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995;87:895-902.
36. Schmitt H, Blin N, Zankl H, Scherthan H. Telomere length variation in normal and malignant human tissues. Genes Chromosom Cancer 1994;11:171-177.
37. Nürnberg P, Thiel G. Weber F, Epplen J. Changes of telomere lengths in human intracranial tumors. Hum Genet 1993;91: 190-2.
38. Wainwright J, Middleton PG, Rees JL. Changes in mean telomere length in basal cell carcinomas of the skin. Genes Chromosom Cancer 1995;12:45-9.
39. Dahse R, Fiedler W, Ernst G, Kosmehl H, Schlichter A, Schubert J, Claussen U. Changes in telomere lengths in renal cell carcinomas. Cell Mol Biol 1996;42:477-85.
40. Rhyu M. Telomeres, telomerase, immortality [Review]. J Natl Cancer Inst 1995;87:885-94.
41. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek M, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995;155:3711-5.
42. Wright W, Piatyszek M, Rainey W, Byrd W, Shay J. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 1996;18:173-9.
43. Yasumoto S, Kunimura C, Kikuchi K, Tahara H, Ohji H, Yamamoto H, et al. Telomerase activity in normal human epithelial cells. Oncogene 1996;13:433-9.
44. Hiyama E, Gollahon L, Kataoka T, Kuroi K, YokoyamaT, Gazdar AF, et al. Telomerase activity in human breast tumors. J Natl Cancer Inst 1996;17:116-22.
45. Sommerfeld HJ, Meeker A, Piatyszek M, Bova S, Shay J, Coffey D. Telomerase activity. A prevalent marker of malignant human prostate tissue. Cancer Res 1996;56:218-22.
46. Langford L, Piatyszek M, Xu R, Schold S, Shay J. Telomerase activity in human brain tumours. Lancet 1995;346:1267-8.
47. Chadeneau C, Hay K, Hirte H, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995;55:2533-6.
48. Schwarte H, Juliao S, Sciadini M, Miller L, Butler M. Telomerase activity and oncogenesis in giant cell tumors of bone. Cancer 1995;75:1094-9.
49. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek M, Shay J. Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med 1995;1:249-55.
50. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, et al. Telomerase activity in gastric cancer. Cancer Res 1995;55:3258-62.
51. Blasco M, Rizen M, Greider C, Hanahan D. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nature Genet 1996;12:200-4.
52. Avilion A, Piatyszek A, Gupta J, Shay J, Bacchetti S, Greider C. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996;56:645-50.
53. Rossi J. Therapeutic antisense and ribozymes. Br Med Bull 1995;51:217-25.
54. Wittung H, Nielsen P, Buchardt O, Egholm M, Norden B. DNA-like double helix formed by peptide nucleic acid. Nature 1994;368: 561-3.
55. Norton J, Piatyszek M, Wright W, Shay J, Corey D. Inhibition of human telomerase activity by peptide nucleic acids. Nature Biotechnol 1996;14:615-9.